Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
King Abdulaziz City For Science And Technology (Kacst) shows a targeted prosecution profile in the Chemistry & Materials technology area. The portfolio currently contains 1 pending office action, which represents the full extent of its current active workload. This matter is assigned to 1 distinct examiner, AKRAM, IMRAN. As the busiest examiner for the portfolio, AKRAM, IMRAN is responsible for 1 pending case. This arrangement indicates that the company's immediate intellectual property goals in the Chemistry & Materials sector are channeled through a single point of contact at the patent office.
The portfolio is further defined by its activity in 1 distinct art unit. This suggests that the technical subject matter is highly specific to a single examination group. For a patent practitioner, managing 1 pending office action under 1 distinct examiner allows for a concentrated legal strategy without the complexities of multi-case coordination. The fact that AKRAM, IMRAN is the sole examiner involved means that the prosecution history will be shaped by a unified perspective. This singular focus within 1 distinct art unit minimizes the potential for conflicting requirements that often arise when a portfolio is spread across different units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOWNSLEY, SARA ELIZABETH | 1 | 25.6% | +48.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17969587 | IMMUNE SUPPRESSING NANOPARTICLES FOR ROBUST SENSITIZATION OF DRUG-RESISTANT CANCER | TOWNSLEY, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17969587 | IMMUNE SUPPRESSING NANOPARTICLES FOR ROBUST SENSITIZATION OF DRUG-RESISTANT CANCER | TOWNSLEY, SARA ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17969587 | IMMUNE SUPPRESSING NANOPARTICLES FOR ROBUST SENSITIZATION OF DRUG-RESISTANT CANCER | TOWNSLEY, SARA ELIZABETH | 1629 | §112 | Final Rejection | — | Pending | Oct 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKing Abdulaziz City For Science And Technology ( Kacst) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sara Elizabeth Townsley has the most, with 1 of King Abdulaziz City For Science And Technology ( Kacst)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
